Torrent Pharmaceuticals has received Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (USFDA) for Oral-Oncology manufacturing facility at Bileshwarpura, Gujarat. The inspection has now been successfully closed by the USFDA. Earlier, USFDA had conducted inspection at the said manufacturing facility from March 13, 2023 to March 17, 2023.
Torrent Pharmaceuticals is flagship company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.
